BofA raised the firm’s price target on Mettler-Toledo (MTD) to $1,390 from $1,260 and keeps a Neutral rating on the shares. While there has been some stabilization and/or improvement in some areas of Life Sciences and Diagnostic Tools, several pockets of uncertainty and softness over the past year remain and are likely to persist for at least the next few quarters, says the analyst, who is trimming forecasts for many core Tools companies and now anticipates a more gradual return to “normal.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD:
- Mettler-Toledo price target raised to $1,600 from $1,400 at Citi
- Mettler-Toledo Appoints Pablo Perversi as New Director
- Mettler-Toledo price target raised to $1,230 from $1,210 at Baird
- Mettler-Toledo’s Strong Q2 Overshadowed by Tariff Concerns and Uncertain Future Growth
- Mettler-Toledo price target raised to $1,150 from $1,100 at Jefferies